Disease: depression

Determination of Tryptamine Alkaloids and Their Stability in Psychotropic Mushrooms

mycolabadmin

Researchers analyzed the active compounds found in psychotropic mushrooms used for therapy and microdosing. They found that the amounts of these compounds vary greatly between mushroom samples and can degrade during storage. Fresh mushrooms stored in freezers degraded faster than dried mushrooms kept at room temperature in the dark, suggesting proper storage is important for maintaining therapeutic effectiveness.

Read More »

Chemical Composition and Biological Activities of Psilocybe Mushrooms: Gaps and Perspectives

mycolabadmin

This review examined research on Psilocybe mushrooms and their chemical compounds, particularly psilocybin and psilocin, which show promise for treating depression and anxiety. The authors found that while these psychoactive compounds have been extensively studied, many other chemical substances in these mushrooms remain unexplored. Additionally, preliminary studies suggest these mushrooms may have antimicrobial and antioxidant properties, though more research is needed. The review highlights significant gaps in understanding the full potential of Psilocybe mushrooms for medical applications.

Read More »

The Benefits and Applications of Lactobacillus plantarum in Food and Health: A Narrative Review

mycolabadmin

Lactobacillus plantarum is a beneficial bacterium commonly found in fermented foods like yogurt and cheese that acts as a natural probiotic. It can help preserve food, improve flavor, and boost health by supporting digestion, strengthening immunity, and reducing inflammation. Research shows it may help with weight management, blood sugar control, and mental health, making it valuable for both the food industry and medical applications.

Read More »

Influences of substrate and tissue type on erinacine production and biosynthetic gene expression in Hericium erinaceus

mycolabadmin

Researchers studied how different growing conditions affect erinacine production in lion’s mane mushroom mycelium. They found that the type of nutrients provided (substrate) significantly influences which erinacines are produced, even when the genes responsible for making these compounds show similar activity levels. Mycelium produced much more erinacines than fruit bodies, and specific nutrients could be used to encourage production of specific beneficial compounds.

Read More »

Cordyceps militaris and Armillaria mellea formula alleviates depressive behaviors via microglia regulation in an unpredictable chronic mild stress animal model

mycolabadmin

Two medicinal mushrooms, Cordyceps militaris and Armillaria mellea, when combined as a formula, can help reduce depression-like symptoms in stressed animals. The formula works by balancing immune cells in the brain called microglia and restoring normal chemical messenger function. This treatment shows promise as a natural alternative to conventional antidepressants with fewer side effects.

Read More »

The regulatory variant rs1950834 confers the risk of depressive disorder by reducing LRFN5 expression

mycolabadmin

Researchers identified a genetic variant (rs1950834) that increases depression risk by reducing production of LRFN5, a protein important for brain connections. They found this variant affects how brain cells in a region called the nucleus accumbens produce LRFN5. When LRFN5 levels are low, mice become more depressed and sensitive to stress, but boosting LRFN5 protects against depression. This discovery could lead to new ways to diagnose and treat depression.

Read More »
Scroll to Top